NAKA vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

NAKA

55.3
AI Score
VS
NAKA Wins

HIVE

54.8
AI Score

Investment Advisor Scores

NAKA

55score
Recommendation
HOLD

HIVE

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAKA HIVE Winner
Revenue 26.58M 79.12M HIVE
Net Income -371.77M -142.91M HIVE
Net Margin -1398.7% -180.6% HIVE
ROE -157.3% -33.8% HIVE
ROA -88.0% -15.5% HIVE
Total Assets 422.51M 924.64M HIVE
Cash 19.07M 208.04M HIVE
Current Ratio 0.15 1.96 HIVE

Relative Price Performance (Last 90 Days)

NAKA 1M: -21.6% · 3M: +63.1% HIVE 1M: -41.4% · 3M: -34.4%

Current Technical Phase

NAKA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.7 · Price: $7.65

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.3%), weak momentum, RSI 24

RSI (14): 23.8 · Price: $1.94

Fundamentals Snapshot

Metric NAKA HIVE
Market Cap — —
Forward P/E -4.0 -3.8
Trailing P/E 4.5 —
Revenue (TTM) — —
Revenue Growth 86.8% 0.7%
Gross Margin -0.4% 0.4%
Operating Margin -0.3% -0.6%
EPS 1.87 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NAKA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.